Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Review

Emerging treatments in type 2 diabetes: focus on canagliflozin

       
Total article views   HTML views PDF downloads Totals
11,842 Dovepress* 9,675+ 2,469 12,144
PubMed Central* 2,167 974 3,141
Totals 11,842 3,443 15,285
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar